REM — Remedis SA Income Statement
0.000.00%
Last trade - 00:00FinancialsHighly SpeculativeMicro Cap
Annual income statement for Remedis SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | PAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.489 | 0.74 | 0.18 | 0.052 | 0.043 |
| Cost of Revenue | |||||
| Gross Profit | 0.04 | 0.433 | 0.077 | 0.044 | 0.042 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 1.63 | 1.7 | 1.4 | 0.832 | 0.972 |
| Operating Profit | -1.15 | -0.961 | -1.22 | -0.78 | -0.929 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1.07 | 0.349 | -1.52 | -0.789 | -2.67 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -1.1 | 0.189 | -1.42 | -0.743 | -2.67 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -1.1 | 0.189 | -1.42 | -0.743 | -2.67 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -1.1 | 0.189 | -1.42 | -0.743 | -2.67 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.014 | 0.008 | -0.019 | -0.008 | -0.039 |
| Dividends per Share |